Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Finance and funding news

Show

From To
Tackling the high price of medicine

Profit seems to be the only logic driving medicine prices, with some African countries paying more for medicine than European countries, and US citizens paying some of the highest medicine prices in the world. While there are global efforts to rein in pharmaceutical companies’ excessive profiteering from sickness, trying to remove the secrecy around prices is complicated.

Published
15 April 2019
From
Daily Maverick
London councils agree to take 60% new PrEP trial patients, but it might not be enough

A stalemate over who would take more patients on to PrEP trial has ended. London councils have agreed to increase places on city PrEP trial.

Published
15 April 2019
From
Gay Star News
Dovato Is a Newly Approved Two-Drug HIV Regimen. Do Fewer Drugs Mean a Lower-Cost HIV Treatment?

When HIV drugmaker ViiV announced in late 2017 that it had received Food and Drug Administration (FDA) approval for Juluca (dolutegravir/rilpivirine), the first effective two-drug, single-pill HIV regimen in the modern treatment era, community activists hoped that its price would reflect the fact that it contained one drug fewer than three-drug tablets like Complera (rilpivirine/tenofovir disoproxil fumarate/FTC), Genvoya (elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide), Stribild (cobicistat/elvitegravir/FTC/tenofovir disoproxil fumarate), and Triumeq (abacavir/dolutegravir/lamivudine), all of which are generally priced between $2,600 and $3,500 a month in the U.S.

Published
15 April 2019
From
The Body
South Africa: Health department scrambles to stop US cut in HIV funds

In a surprise move barely six weeks after announcing that SA was to get an extra $1.2bn to support its HIV/AIDS programmes over the next two years, US global AIDS coordinator Deborah Birx said Pepfar’s programmes are performing so poorly in SA that funding should be cut from the start of the next US financial year, which begins on October 1.

Published
12 April 2019
From
Business Day
London: Tower Hamlets Mayor calls for Government to fund PrEP for all to stop HIV transmission

John Biggs, Mayor of Tower Hamlets has written to Matt Hancock the Secretary of State for health, to call for the funding of HIV treatment that could stop the spread of HIV, saving the NHS millions of pounds.

Published
11 April 2019
From
Tower Hamlets council
Sticker Shock: PrEP Is Not Cost-Effective at Current Price, Health Economists Find

For years, the U.S. HIV prevention community has known that pre-exposure prophylaxis (PrEP) is prohibitively expensive for many patients who need it. Now, new research presented at the 2019 National HIV Prevention Conference (NHPC) in Atlanta finds that not only is PrEP expensive for individual patients, it's also not cost-effective for the health system as a whole.

Published
09 April 2019
From
The Body
Councils seek NHS funding to cover drug trial pressures

London councils seeking “additional funding” from NHS England to help cover costs of PrEP trial places. Thousands of trial places at risk unless NHS provides around £3.5m. Fifteen MPs and Lords’ members have written to Matt Hancock to demand “sustainable solution”

Published
27 March 2019
From
Health Service Journal
Project Inform expected to close

Project Inform, one of the nation's longest-running HIV education and advocacy organizations, has terminated its staff and is likely to cease operations, the Bay Area Reporter has learned.

Published
15 March 2019
From
Bay Area Reporter
Trump Budget Proposes Largest Ever Cuts to Global HIV Programs

Just one month ago, President Trump promised during the State of the Union Address to defeat HIV in the U.S. and beyond. But the president’s budget proposal to Congress today—which threatens to gut life-saving HIV treatment and prevention programs—unmasks his lies. If implemented, Trump’s proposal would wipe out years of progress in the effort to end the AIDS pandemic.

Published
14 March 2019
From
Health GAP
Trump’s Proposed Budget Undermines His H.I.V. Plan, Experts Say

Strategies abound to end the AIDS epidemic, but expense — mostly for drugs costing up to $50,000 a year — is the inevitable obstacle.

Published
14 March 2019
From
The New York Times
← First12345...106Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.